Limited short-term steroid responsiveness is associated with thickening of bronchial basement membrane in severe asthma

Chest

Volumn 141, Issue 6, 2012, Pages 1504-1511

  Bourdin, Arnaud ^a   Kleis, Stephane ^a   Chakra, Mohamad ^a   Vachier, Isabelle ^a   Paganin, Fabrice ^b   Godard, Philippe ^a   Chanez, Pascal ^c,d  

^a INSERM   (France)

^b Groupe Hospitalier Sud Reunion   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEPREDNISONE; STEROID;

ADULT; AGED; AIRWAY OBSTRUCTION; AIRWAY REMODELING; ARTICLE; ASTHMA; BASEMENT MEMBRANE; BRONCHOSCOPY; BRONCHUS BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETICULAR BASEMENT MEMBRANE THICKNESS;

EID: 84862001931     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0232     Document Type: Article

References (29)

1. Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol. 2007;119(6):1337-1348. (Pubitemid 46863369)
2. James AL, Maxwell PS, Pearce-Pinto G, Elliot JG, Carroll NG. The relationship of reticular basement membrane thickness to airway wall remodeling in asthma. Am J Respir Crit Care Med. 2002;166(12 pt 1):1590-1595. (Pubitemid 36015954)
3. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003;168(8):983-988. (Pubitemid 37267177)
4. Bourdin A, Neveu D, Vachier I, Paganin F, Godard P, Chanez P. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol. 2007;119(6):1367-1374. (Pubitemid 46855858)
5. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy. 1997;27(4):363-371. (Pubitemid 27183358)
6. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218-224.
7. Moore WC, Meyers DA, Wenzel SE, et alNational Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315-323.
8. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med. 2004;170(6):601-605. (Pubitemid 39202200)
9. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360(10):973-984.
10. Flood-Page P, Swenson C, Faiferman I, et alInternational Mepolizumab Study Group. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007; 176(11):1062-1071. (Pubitemid 350223751)
11. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 2003;167(2):199-204. (Pubitemid 36076080)
12. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009;360(10):985-993.
13. Demoly P, Jaffuel D, Mathieu M, et al. Glucocorticoid insensitive asthma: a one year clinical follow up pilot study. Thorax. 1998;53(12):1063-1065. (Pubitemid 28567009)
14. Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol. 2007;119(5):1055-1062. (Pubitemid 46654167)
15. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J. 1998;12(5):1209-1218. (Pubitemid 28545638)
16. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804-813. (Pubitemid 44279058)
17. Paganin F, Séneterre E, Chanez P, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med. 1996;153(1):110-114. (Pubitemid 26026835)
18. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115(5):1265-1270. (Pubitemid 29230632)
19. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-907. (Pubitemid 29519356)
20. Jeffery P, Holgate S, Wenzel S; Endobronchial Biopsy Workshop. Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. Am J Respir Crit Care Med. 2003;168(6 pt 2):S1-S17. (Pubitemid 37175959)
21. Sullivan P, Stephens D, Ansari T, Costello J, Jeffery P. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J. 1998;12(4):811-815. (Pubitemid 28491649)
22. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J. 2007;30(1):134-155. (Pubitemid 47074016)
23. Hirota JA, Hackett TL, Inman MD, et al. Modeling asthma in mice: what have we learned about the airway epithelium? Am J Respir Cell Mol Biol. 2011;44(4):431-438.
24. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388-395.
25. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-1039. (Pubitemid 20336962)
26. Chakir J, Loubaki L, Laviolette M, et al. Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study. Eur Respir J. 2010;35(1):48-53.
27. Grainge CL, Lau LC, Ward JA, et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med. 2011;364(21):2006-2015.
28. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177(2):148-155.
29. Silkoff PE, Lent AM, Busacker AA, et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol. 2005;116(6):1249-1255 (Pubitemid 41740931)